04/26/2016
https://congress.gov...
"I propose that maybe we need a price protection program for public health drugs, and that we need to decide a public formulary."
"There's one message for us here in the public and quite another for investors."
"You should foresee that just continuing as we continue to maximize the EpiPen franchise."
"You virtually have a monopoly and you've used it to your advantage, but, unfortunately, it's at the expense of people who need it."